|
Verenium and BP Extend Galaxy Joint Development Program
09 March 2010
Verenium to receive an additional $2.5 million from BP to co-fund the cellulosic ethanol program for the month of March.
|
|
|
|
Denator AB Expands and Strengthens Commercial Operations
08 March 2010
The Company has announced the appointment of Patrik Bjoorn as Application Specialist with the responsibility for Technical Support.
|
|
|
|
Polyplus-transfection Licenses ZNA™ Oligonucleotide Technology to Metabion
04 March 2010
Metabion will manufacture and commercialize custom ZNA oligonucleotides for research and in vitro diagnostic applications.
|
|
|
|
MorphoSys AG Reports Positive Results for Fiscal Year 2009
03 March 2010
The Company has increased full-year Group revenues by 13 percent to EUR 81.0 million.
|
|
|
|
Astech Projects Expands its Packaging Robotics and Automation Offering
26 February 2010
Company appoints John Roberts to expand its sales team within the Packaging Robotics and Consumer Goods Testing markets.
|
|
|
|
BioProcess Technology Consultants Publishes Report on Development of Therapeutic Monoclonal Antibody Products
26 February 2010
Report includes information on late-stage development of monoclonal antibody products and presents strategies for accelerating their development.
|
|
|
|
Galapagos Delivers Third Candidate Drug in GSK Alliance, Receives €5.7 Million
23 February 2010
Galapagos will now start scale-up chemistry and safety evaluation to initiate Phase I clinical trials early 2011.
|
|
|
|
PA Consulting Group Announces Collaboration with 4D Biomedical
23 February 2010
The collaborations is aimed to explore and develop growing field of experimental medicine.
|
|
|
|
Recipharm Biologics and Cobra Biomanufacturing plc Combine
23 February 2010
The combination of both companies capabilities will offers a comprehensive range of services to pharma and biotech sectors.
|
|
|
|
Karus Therapeutics Extends Drug Discovery Programme to Target HDAC-6
22 February 2010
The Company has designed and developed a novel series of highly potent and selective HDAC-6 inhibitors for anti-inflammatory activity.
|
|
|
|
MorphoSys and Galapagos Expand Antibody Alliance
22 February 2010
The partners have agreed to add another antibody target to the alliance, increasing the total number of programs to four.
|
|
|
|
Waters and DAISO Sign Marketing Agreement for Bulk Process Chromatography Media
18 February 2010
Waters to make DAISO media available to pharmaceutical and biopharmaceutical purification customers.
|
|
|
|
Microsonic Systems HENDRIX SM100™ Now Serving Four Applications – Solubilization, Thawing, Mixing and Suspension
18 February 2010
At the “Late night with LRIG” rapid fire session during the recent Lab Automation conference in Palm Springs, Microsonic Systems announced that its HENDRIX SM100 now serves four key applications: Compound solubilization, Sample thawing, Microplate mixing, and Magnetic particles/cells suspension.
|
|
|
|
Gyros and SCRUM Sign Distribution Agreement for the Japanese Market
17 February 2010
SCRUM will market, sell and fully support the Gyros product range, within the Japanese life-science market industries.
|
|
|
|
Biocartis Acquires Philips Technology Platform for Automated DNA/RNA Molecular Diagnostic Testing
15 February 2010
Biocartis plans to develop and commercialize the platform, together with a menu of tests, through strategic partnerships.
|
|
|
|
Biovail Enters into License and Collaboration Agreement with Alexza for AZ-004
15 February 2010
BLS has acquired the U.S. and Canadian rights to commercialize AZ-004.
|
|
|